Lv1
40 积分 2024-11-25 加入
Genetic predictors of GLP1 receptor agonist weight loss and side effects
1个月前
已完结
Refining the link between obesity and heart failure: insights from GLP-1 receptor agonist trials and studies adopting direct adiposity measures
1个月前
已完结
Obesity Treatments and Weight Changes in Clinical Practice After Discontinuation of Semaglutide or Tirzepatide
2个月前
已完结
Obesity Treatments and Weight Changes in Clinical Practice After Discontinuation of Semaglutide or Tirzepatide
2个月前
已完结
Prospective Associations of Obesity and Obesity Severity With 9 Cardiovascular Outcomes: The Cross-Cohort Collaboration
2个月前
已完结
Discovery of Gut-Targeted GPR40 Agonist K-757 and GPR119 Agonist K-833, a Combination Treatment for Metabolic Disorders
2个月前
已完结
Gut enteroendocrine cell activation using a combination of GPR119 and GPR40 agonists results in synergistic hormone secretion in mice and humans
3个月前
已完结
Gut enteroendocrine cell activation using a combination of GPR119 and GPR40 agonists results in synergistic hormone secretion in mice and humans
3个月前
已完结
GLP-1 receptor agonists and coronary plaques regression in diabetic patients after acute coronary syndromes
3个月前
已完结
GLP-1 receptor agonists and coronary plaques regression in diabetic patients after acute coronary syndromes
3个月前
已完结
皖公网安备34019202002308
